Frequency of respiratory virus-associated infection among children and adolescents from a tertiary-care hospital in Mexico City
Por:
Nieto-Rivera B., Saldaña-Ahuactzi Z., Parra-Ortega I., Flores-Alanis A., Carbajal-Franco E., Cruz-Rangel A., Galaviz-Hernández S., Romero-Navarro B., de la Rosa-Zamboni D., Salazar-García M., Contreras C.A., Ortega-Riosvelasco F., López-Martínez I., Barrera-Badillo G., Diaz-Garcia H., Romo-Castillo M., Moreno-Espinosa S., Luna-Pineda V.M.
Publicada:
1 ene 2023
Categoría:
Multidisciplinary
Resumen:
Acute respiratory infections (ARIs) are a major cause of morbidity and mortality among children. The causative pathogens show geographic and seasonal variations. We retrospectively evaluated the frequency and seasonality of respiratory pathogens in children and adolescents (age: 0–19 years) with ARIs treated between January 1, 2021, and March 31, 2022, at a single center in Mexico. Out of 2400 patients, 1,603 were diagnosed with SARS-CoV-2 infection and 797 were diagnosed with other common respiratory pathogens (CRPs). Of the 797 patients, 632 were infected with one CRP and 165 with > 2 CRPs. Deaths occurred only in SARS-CoV-2-infected patients. Rhinovirus/Enterovirus, respiratory syncytial virus B, and parainfluenza virus 3 were the most prevalent in cases with single and multiple infections. CRP showed a high frequency between autumn and winter of 2021, with higher incidence of hospitalization compared to COVID-19. The main comorbidities were immunosuppression, cardiovascular disease (CD), and asthma. The frequency of CRPs showed a downward trend throughout the first half of 2021. CRPs increased in single- and co-infection cases between the fourth and fifth waves of COVID-19, probably due to decreased nonpharmaceutical interventions and changes in diagnostic tests. Age, cyanosis (symptom), and immunosuppression (comorbidity) were found to differentiate between SARS-CoV-2 infection and CRP infection. © 2023, The Author(s).
Filiaciones:
Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Centro de Investigación en Biotecnología Aplicada, Instituto Politécnico Nacional, Santa Inés Tecuexcomac, Tlaxcala, Tepetitla de Lardizábal, Mexico
Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
Laboratorio de Bioquímica de Enfermedades Crónicas, Instituto Nacional de Medicina Genómica, Ciudad de México, Mexico
Subdirección de Servicios Auxiliares de Diagnóstico, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Subdirección de Atención Integral al Paciente, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Laboratorio de Biología del Desarrollo y Teratogénesis Experimental, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Facultad de Medicina, Universidad Privada Antenor Orrego, Trujillo, Peru
Departamento de Epidemiología Clínica, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Dirección de Diagnóstico y Referencia, Instituto de Diagnóstico y Referencia Epidemiológicos, Ciudad de México, Mexico
Laboratorio de Virus Respiratorios, Instituto de Diagnóstico y Referencia Epidemiológicos, Ciudad de México, Mexico
Centro de Investigación en Malformaciones Congénitas, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Escuela Superior de Enfermería y Obstetricia, Instituto Politécnico Nacional, Ciudad de México, Mexico
Laboratorio de Investigación en COVID-19, Laboratorio de Investigación en Inmunología y Proteomica, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Dirección de Enseñanza, Hospital Infantil de México Federico Gómez, Ciudad de México, Mexico
Green Submitted, Green Published, gold, All Open Access, Gold, Green
|